Ficerafusp Alfa
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Ficerafusp Alfa, covering 2026-03-23 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma [Phase 2]